Richard Ries, MD, FAPA, FASM

Faculty Appointment(s)

Professor, Department of Psychiatry and Behavioral Sciences

Leadership Role(s)

Director, Division of Addictions

Co-Director, Psychiatry and Addictions Case Conference (PACC) series

rries@uw.edu

206-341-4216

UW Medicine profile »

Personal Statement

I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington  School of Medicine in Seattle, Washington. I am also the clinical director of  addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.

I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.

Education

Northwestern Univ. Medical School Medical education, 1975
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Centers/Programs
Training Programs

Recent Publications

Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use Disorder.
(2023 May-Jun 01)
J Addict Med 17(3): 305-311
Jett JD, Kordas G, Parent S, Keshtkar M, Shin R, King P, McPherson SM, Ries R, Roll JM, McDonell MG, Chaytor N
Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use Disorder.
(2022 Nov 8)
J Addict Med
Jett JD, Kordas G, Parent S, Keshtkar M, Shin R, King P, McPherson SM, Ries R, Roll JM, McDonell MG, Chaytor N
Delivering Remote Measurement-Based Care in Community Addiction Treatment: Engagement and Usability Over a 6-Month Clinical Pilot.
(2022)
Front Psychiatry 13(): 840409
Hallgren KA, Cohn EB, Ries RK, Atkins DC
Effectiveness of a Suicide Prevention Module for Adults in Substance Use Disorder Treatment: A Stepped-Wedge Cluster-Randomized Clinical Trial.
(2022 Apr 1)
JAMA Netw Open 5(4): e222945
Ries RK, Livengood AL, Huh D, Kerbrat AH, Fruhbauerova M, Turner B, Comtois KA
Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults.
(2022 Jun)
J Subst Abuse Treat 137(): 108693
Hirchak KA, Lyons AJ, Herron JL, Kordas G, Shaw JL, Jansen K, Avey JP, McPherson SM, Donovan D, Roll J, Buchwald D, Ries R, McDonell MG, HONOR Study Team
Show complete publication list »
Edit Profile